Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
04-Sep-2025 | 5,380 | 5,380 | 5,289.5 | 5,301.5 | 20,626 | 70,07,29,780.5 | 88,584 |
05-Sep-2025 | 5,323.5 | 5,369 | 5,277 | 5,333.5 | 26,451 | 1,26,61,36,372.5 | 1,85,706 |
08-Sep-2025 | 5,340 | 5,382.5 | 5,300.5 | 5,333 | 10,277 | 21,23,74,723 | 21,404 |
09-Sep-2025 | 5,321 | 5,370 | 5,321 | 5,336 | 20,893 | 49,16,37,580.5 | 65,729 |
10-Sep-2025 | 5,359.5 | 5,400 | 5,298 | 5,320.5 | 18,313 | 1,01,71,83,257 | 1,38,816 |
11-Sep-2025 | 5,361.5 | 5,429 | 5,326.5 | 5,393.5 | 15,709 | 1,90,43,48,444 | 2,99,879 |
12-Sep-2025 | 5,393.5 | 5,459.5 | 5,390.5 | 5,448 | 14,901 | 65,64,88,379 | 79,355 |
15-Sep-2025 | 5,460 | 5,530.5 | 5,391 | 5,500.5 | 18,510 | 94,40,98,064.5 | 92,576 |
16-Sep-2025 | 5,525 | 5,545 | 5,468.5 | 5,503 | 14,797 | 38,83,59,191.5 | 41,544 |
17-Sep-2025 | 5,507 | 5,529 | 5,454.5 | 5,472.5 | 16,648 | 52,63,36,266 | 53,338 |
18-Sep-2025 | 5,502 | 5,502 | 5,456 | 5,479.5 | 16,255 | 87,99,04,867.5 | 1,29,958 |
19-Sep-2025 | 5,486 | 5,575.5 | 5,481 | 5,541.5 | 27,271 | 2,12,42,96,699.5 | 2,81,310 |
22-Sep-2025 | 5,559 | 5,559 | 5,467 | 5,495 | 32,862 | 2,10,17,08,324 | 3,38,272 |
23-Sep-2025 | 5,549 | 5,577.5 | 5,500 | 5,544.5 | 27,994 | 1,33,13,24,933.5 | 1,72,665 |
24-Sep-2025 | 5,545.5 | 5,586.5 | 5,531.5 | 5,576 | 17,273 | 87,20,58,425 | 1,13,019 |
25-Sep-2025 | 5,591 | 5,591 | 5,484.5 | 5,508 | 29,270 | 1,60,70,35,483.5 | 2,22,999 |
26-Sep-2025 | 5,480 | 5,492 | 5,362.5 | 5,433 | 22,834 | 98,74,73,588 | 91,290 |
29-Sep-2025 | 5,400 | 5,457 | 5,378.5 | 5,409 | 25,435 | 99,67,49,856.5 | 1,26,945 |
30-Sep-2025 | 5,457 | 5,460.5 | 5,375.5 | 5,425 | 17,482 | 39,47,09,496.5 | 40,222 |
01-Oct-2025 | 5,392 | 5,486.5 | 5,390.5 | 5,459.5 | 25,776 | 96,74,60,837 | 1,11,622 |
03-Oct-2025 | 5,519 | 5,519 | 5,425 | 5,442 | 17,112 | 60,43,34,335 | 74,421 |
This inspection, conducted from March 10 through March 13, 2025, was to evaluate compliance with the legal standards concerning bioequivalence studies.
The company saw its revenues increase by 1.5% YoY at ₹3,374 crore from ₹3,324 crore.
The serum contains liposomal azelaic acid, liposomal 4-butyl resorcinol, tranexamic acid, alpha arbutin, and niacinamide.
R&D expenses rose to ₹146.5 crore, making up 4.3% of total revenue, compared to ₹115.8 crore (3.4% of revenue) in the previous year.
This comes after competing private equity firms TPG Capital, Apax Partners, and KKR withdrew their original interest.
Alkem will conduct clinical trials of 'SON-080' in India, with Sonnet's support for global and local regulatory submissions.
According to sources, the floor price would be ₹5,616 per share, which is 3% lower than the current market price (CMP).
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
